Umbertina Conti Reed

Summary

Country: Brazil

Publications

  1. pmc Lung function monitoring in patients with duchenne muscular dystrophy on steroid therapy
    Darlene L Machado
    Department of Neurology, Medical School of the University of São Paulo, Av, Dr, Enéas de Carvalho Aguiar 255, room 5131, Cerqueira Cesar, Sao Paulo, 05403900, Brazil
    BMC Res Notes 5:435. 2012
  2. pmc Evaluation of muscle strength and motor abilities in children with type II and III spinal muscle atrophy treated with valproic acid
    Illora A Darbar
    Department of Neurology, Medical School of the University of São Paulo, Sao Paulo, Brazil
    BMC Neurol 11:36. 2011
  3. ncbi Congenital muscular dystrophy. Part II: a review of pathogenesis and therapeutic perspectives
    Umbertina Conti Reed
    Departamento de Neurologia, Universidade de Sao Paulo, SP, Brazil
    Arq Neuropsiquiatr 67:343-62. 2009
  4. ncbi Congenital muscular dystrophy. Part I: a review of phenotypical and diagnostic aspects
    Umbertina Conti Reed
    Departamento de Neurologia, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, SP, Brazil
    Arq Neuropsiquiatr 67:144-68. 2009
  5. ncbi Schwartz-Jampel syndrome: report of five cases
    Umbertina Conti Reed
    Department of Neurology, School of Medicine, Sao Paulo University, Sao Paulo, SP, Brasil
    Arq Neuropsiquiatr 60:734-8. 2002
  6. ncbi King-Denborough Syndrome: report of two Brazilian cases
    Umbertina Conti Reed
    Department of Neurology, Clinicas Hospital, School of Medicine, University of Sao Paulo, Sao Paulo, SP, Brazil
    Arq Neuropsiquiatr 60:739-41. 2002
  7. ncbi Ullrich congenital muscular dystrophy and Bethlem myopathy: clinical and genetic heterogeneity
    Umbertina Conti Reed
    Departamento de Neurologia, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brasil
    Arq Neuropsiquiatr 63:785-90. 2005
  8. ncbi Dystrophin-glycoproteins associated in congenital muscular dystrophy: immunohistochemical analysis of 59 Brazilian cases
    Lucio Gobbo Ferreira
    Departamento de Neurologia, Faculdade de Medicina, , , Brasil
    Arq Neuropsiquiatr 63:791-800. 2005
  9. ncbi Comparison of motor strength and function in patients with Duchenne muscular dystrophy with or without steroid therapy
    Samara Lamounier Santana Parreira
    Department of Neurology, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil
    Arq Neuropsiquiatr 68:683-8. 2010
  10. pmc Phenotypic and immunohistochemical characterization of sarcoglycanopathies
    Ana F B Ferreira
    Department of Neurology, Laboratory of Investigation in Neurology, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil
    Clinics (Sao Paulo) 66:1713-9. 2011

Collaborators

  • Samara Lamounier Santana Parreira
  • Ana F B Ferreira
  • Rubens Reimao
  • Edmar Zanoteli
  • Darlene L Machado
  • Carmen Silvia Molleis Galego Miziara
  • Valdecir A Simon
  • Illora A Darbar
  • Maria Conceptión García Otaduy
  • Fernando Kok
  • Cleurecy Oliveira Vasques
  • Lucio Gobbo Ferreira
  • Celso R F Carvalho
  • Laura Maria Figueiredo Ferreira Guilhoto
  • Elaine C Silva
  • Maria Luiza Giraldes de Manreza
  • Virginia Aparecida Gelmeti Serrano
  • Letícia Mansur
  • Solange Góis
  • Maria B D Resende
  • Margarete A V P Simon
  • Paulo G Plaggert
  • Maria Bernadete D Resende
  • Maria Bernardete Dutra Resende
  • Marco da Cunha Pinho
  • Clarissa Bueno
  • Claudia da Costa Leite
  • Lídia Mayumi Nagae
  • Enna Cristina Liu
  • Milberto Scaff
  • Suely Kazue Marie
  • Mary Souza Carvalho
  • Maria Bernadete Dutra Resende
  • Rosi Mary Grossman
  • Rosa Maria Figueiredo Valério

Detail Information

Publications15

  1. pmc Lung function monitoring in patients with duchenne muscular dystrophy on steroid therapy
    Darlene L Machado
    Department of Neurology, Medical School of the University of São Paulo, Av, Dr, Enéas de Carvalho Aguiar 255, room 5131, Cerqueira Cesar, Sao Paulo, 05403900, Brazil
    BMC Res Notes 5:435. 2012
    ..After 12 years of age, lung function declines at a rate of 6 % to 10.7 % per year in patients with DMD. Steroid therapy has been proposed to delay the loss of motor function and also the respiratory involvement...
  2. pmc Evaluation of muscle strength and motor abilities in children with type II and III spinal muscle atrophy treated with valproic acid
    Illora A Darbar
    Department of Neurology, Medical School of the University of São Paulo, Sao Paulo, Brazil
    BMC Neurol 11:36. 2011
    ..Knowledge of the molecular mechanism of diseases has led to the discovery of drugs capable of increasing SMN protein level through activation of SMN2 gene. One of these drugs is the valproic acid (VPA), a histone deacetylase inhibitor...
  3. ncbi Congenital muscular dystrophy. Part II: a review of pathogenesis and therapeutic perspectives
    Umbertina Conti Reed
    Departamento de Neurologia, Universidade de Sao Paulo, SP, Brazil
    Arq Neuropsiquiatr 67:343-62. 2009
    ....
  4. ncbi Congenital muscular dystrophy. Part I: a review of phenotypical and diagnostic aspects
    Umbertina Conti Reed
    Departamento de Neurologia, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, SP, Brazil
    Arq Neuropsiquiatr 67:144-68. 2009
    ..The second part of this review concerning the pathogenesis and therapeutic perspectives of the different subtypes of CMD will be described in a next number...
  5. ncbi Schwartz-Jampel syndrome: report of five cases
    Umbertina Conti Reed
    Department of Neurology, School of Medicine, Sao Paulo University, Sao Paulo, SP, Brasil
    Arq Neuropsiquiatr 60:734-8. 2002
    ..Carbamazepine in SJS-type 1 improves general daily performance and psychological status of the patients...
  6. ncbi King-Denborough Syndrome: report of two Brazilian cases
    Umbertina Conti Reed
    Department of Neurology, Clinicas Hospital, School of Medicine, University of Sao Paulo, Sao Paulo, SP, Brazil
    Arq Neuropsiquiatr 60:739-41. 2002
    ..These cases correspond to the first Brazilian reports of the King-Denborough syndrome and our objective is increasing the awareness of this disorder as these patients are predisposed to developing malignant hyperthermia...
  7. ncbi Ullrich congenital muscular dystrophy and Bethlem myopathy: clinical and genetic heterogeneity
    Umbertina Conti Reed
    Departamento de Neurologia, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brasil
    Arq Neuropsiquiatr 63:785-90. 2005
    ..A mild or moderate involvement can be occasionally observed...
  8. ncbi Dystrophin-glycoproteins associated in congenital muscular dystrophy: immunohistochemical analysis of 59 Brazilian cases
    Lucio Gobbo Ferreira
    Departamento de Neurologia, Faculdade de Medicina, , , Brasil
    Arq Neuropsiquiatr 63:791-800. 2005
    ....
  9. ncbi Comparison of motor strength and function in patients with Duchenne muscular dystrophy with or without steroid therapy
    Samara Lamounier Santana Parreira
    Department of Neurology, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil
    Arq Neuropsiquiatr 68:683-8. 2010
    ..To compare muscle strength (MS) and motor function in patients with Duchenne muscular dystrophy (DMD) receiving steroids for different times against the natural evolution of DMD described by Scott et al...
  10. pmc Phenotypic and immunohistochemical characterization of sarcoglycanopathies
    Ana F B Ferreira
    Department of Neurology, Laboratory of Investigation in Neurology, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil
    Clinics (Sao Paulo) 66:1713-9. 2011
    ..Therefore, determining the etiology of a given sarcoglycanopathy requires costly and occasionally inaccessible molecular methods...
  11. ncbi Quantification of muscle strength and motor ability in patients with Duchenne muscular dystrophy on steroid therapy
    Samara Lamounier Santana Parreira
    Department of Neurology, Medical School, University of Sao Paulo, Sao Paulo, SP, Brazil
    Arq Neuropsiquiatr 65:245-50. 2007
    ..An assessment protocol was applied to quantify and describe muscular strength and motor abilities of 32 patients with Duchenne muscular dystrophy (DMD), aged between 5 and 12 years on steroid therapy...
  12. ncbi Duchenne muscular dystrophy: quality of life among 95 patients evaluated using the Life Satisfaction Index for Adolescents
    Valdecir A Simon
    Department of Neurology, School of Medicine, University of Sao Paulo, SP, Brazil
    Arq Neuropsiquiatr 69:19-22. 2011
    ..The use of a scale that embraces a great diversity of circumstances in patients' lives, without considering clinical aspects excessively, is a good alternative for assessing the QoL of these patients...
  13. doi Impact of benign childhood epilepsy with centrotemporal spikes (BECTS) on school performance
    Carmen Silvia Molleis Galego Miziara
    Department of Pediatric Neurology, Hospital das Clínicas Faculty of Medicine, Sao Paulo University, Sao Paulo, Brazil
    Seizure 21:87-91. 2012
    ..Owing to the age peculiarity of children who suffer from this disease, i.e., school-going age of between 6 and 9 years, the condition is often referred to as a school disorder by parents and teachers...
  14. ncbi Further diffusion tensor imaging contribution in horizontal gaze palsy and progressive scoliosis
    Maria Conceptión García Otaduy
    Department of Radiology, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil
    Arq Neuropsiquiatr 67:1054-6. 2009
    ..Those findings can contribute as surrogate markers for the diagnosis...
  15. ncbi [Pitfalls in the clinical and electroencephalographic diagnosis of ceroid lipofuscinosis]
    Cleurecy Oliveira Vasques
    Divisão de Clínica Neurológica, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil
    Arq Neuropsiquiatr 63:93-6. 2005
    ..Electroencephalogram is useful for clinical diagnosis of NCL but it is not helpful in its classification...